학술논문

Preclinical characterization of ETx-22, a next-generation antibody drug conjugate (ADC) targeting nectin-4
Document Type
Journal
Source
MOLECULAR CANCER THERAPEUTICS; DEC 2023, 22 12, 2p. Supplement: S
Subject
Language
English
ISSN
15388514